Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Rev Esp Enferm Dig ; 111(2): 168-169, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30318896

ABSTRACT

Type III glycogen storage disease (GSD-III) is an autosomal recessive disorder due to the deficiency of the glycogen debrancher enzyme. 80% of the patients have hepatic and muscular involvement (IIIa), compared to 15% with only liver involvement (IIIb). As the life expectancy improves in these patients, the possible liver complications are better understood.


Subject(s)
Carcinoma, Hepatocellular/surgery , Glycogen Storage Disease Type III/surgery , Liver Cirrhosis/surgery , Liver Neoplasms/surgery , Liver Transplantation , Adult , Glycogen Storage Disease Type III/complications , Humans , Male , Middle Aged , Neoplasm Recurrence, Local
3.
Rev Esp Enferm Dig ; 110(9): 589-590, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30032632

ABSTRACT

We report the case of a 67-year-old male with epigastric pain and weight loss during the last nine months. Physical examination revealed a hard palpable mass in the epi-mesogastrium. An abdominal ultrasound identified a large, heterogeneous and hypovascular mass, which compressed the left hepatic lobe and the pancreas.


Subject(s)
Abdominal Neoplasms/diagnostic imaging , Abdominal Neoplasms/pathology , Liposarcoma/diagnostic imaging , Liposarcoma/pathology , Abdominal Neoplasms/surgery , Aged , Duodenal Neoplasms/diagnosis , Duodenal Neoplasms/pathology , Duodenal Neoplasms/surgery , Endosonography , Humans , Liposarcoma/surgery , Male , Tomography, X-Ray Computed
6.
Gastroenterol. hepatol. (Ed. impr.) ; 40(2): 70-79, feb. 2017. ilus, tab, graf
Article in Spanish | IBECS | ID: ibc-160349

ABSTRACT

INTRODUCCIÓN: el uso de la enteroscopia con videocápsula fue aprobado por la FDA en 2001. La hemorragia digestiva y la enfermedad inflamatoria intestinal son sus principales indicaciones. En nuestro centro se realiza desde 2004. MATERIAL Y MÉTODOS: Hemos recogido de forma retrospectiva los pacientes tratados mediante cápsula de intestino delgado desde octubre de 2004 hasta abril de 2015. Las indicaciones se han dividido en grupos: hemorragia digestiva de origen oscuro, tanto oculta como manifiesta; enfermedad inflamatoria intestinal; otras indicaciones. Los hallazgos se han dividido: lesiones vasculares; lesiones inflamatorias; otras lesiones; estudios normales; estudios no concluyentes. RESULTADOS: De un total de 1.291 estudios se ha incluido 1.027 en el análisis. La edad media es 56,45 años, con 471 hombres y 556 mujeres. La enfermedad más frecuentemente observada fueron las lesiones vasculares, asociadas o no a otras lesiones. Cuando la indicación era una hemorragia digestiva, el impacto diagnóstico fue del 80%. En la enfermedad inflamatoria esta cifra solo alcanza el 50%. El rendimiento diagnóstico es mucho menor en el grupo de «otras indicaciones». No se han registrado complicaciones mayores. DISCUSIÓN: La cápsula de intestino delgado tiene un alto rendimiento diagnóstico en los casos de hemorragia digestiva; el número de estudios con hallazgos positivos es menor en los de enfermedad inflamatoria intestinal. CONCLUSIONES: Se trata de una modalidad diagnóstica segura y de gran utilidad para el diagnóstico de enfermedad del intestino delgado, aunque se precisa mejorar el índice de sospecha en la enfermedad inflamatoria intestinal


INTRODUCTION: Capsule endoscopy was approved by the FDA in 2001. Gastrointestinal bleeding and inflammatory bowel disease are the main indications. It has been available in our hospital since 2004. METHODS: We retrospectively analysed data from patients who underwent small bowel capsule endoscopy in our hospital from October 2004 to April 2015. Indications were divided into: Obscure gastrointestinal bleeding (occult and overt), inflammatory bowel disease, and other indications. Findings were divided into: Vascular lesions, inflammatory lesions, other lesions, normal studies, and inconclusive studies. RESULTS: A total of 1027 out of 1291 small bowel studies were included. Mean patient age was 56.45 years; 471 were men and 556 women. The most common lesion observed was angiectasia, as an isolated finding or associated with other lesions. Findings were significant in up to 80% of studies when the indication was gastrointestinal bleeding, but in only 50% of studies in inflammatory bowel disease. Diagnostic yield was low in the group «other indications». No major complications were reported. DISCUSSION: Small bowel capsule endoscopy has high diagnostic yield in patients with gastrointestinal bleeding, but yield is lower in patients with inflammatory bowel disease. CONCLUSIONS: Our experience shows that capsule endoscopy is a safe and useful tool for the diagnosis of small bowel disease. The diagnostic yield of the technique in inflammatory bowel disease must be improved


Subject(s)
Humans , Inflammatory Bowel Diseases/diagnosis , Intestine, Small/physiopathology , Capsule Endoscopy/trends , Capsule Endoscopes/trends , Tertiary Healthcare , Endoscopy, Digestive System/methods , Gastrointestinal Hemorrhage/diagnosis
7.
Gastroenterol Hepatol ; 40(2): 70-79, 2017 Feb.
Article in English, Spanish | MEDLINE | ID: mdl-27242156

ABSTRACT

INTRODUCTION: Capsule endoscopy was approved by the FDA in 2001. Gastrointestinal bleeding and inflammatory bowel disease are the main indications. It has been available in our hospital since 2004. METHODS: We retrospectively analysed data from patients who underwent small bowel capsule endoscopy in our hospital from October 2004 to April 2015. Indications were divided into: Obscure gastrointestinal bleeding (occult and overt), inflammatory bowel disease, and other indications. Findings were divided into: Vascular lesions, inflammatory lesions, other lesions, normal studies, and inconclusive studies. RESULTS: A total of 1027 out of 1291 small bowel studies were included. Mean patient age was 56.45 years; 471 were men and 556 women. The most common lesion observed was angiectasia, as an isolated finding or associated with other lesions. Findings were significant in up to 80% of studies when the indication was gastrointestinal bleeding, but in only 50% of studies in inflammatory bowel disease. Diagnostic yield was low in the group «other indications¼. No major complications were reported. DISCUSSION: Small bowel capsule endoscopy has high diagnostic yield in patients with gastrointestinal bleeding, but yield is lower in patients with inflammatory bowel disease. CONCLUSIONS: Our experience shows that capsule endoscopy is a safe and useful tool for the diagnosis of small bowel disease. The diagnostic yield of the technique in inflammatory bowel disease must be improved.


Subject(s)
Capsule Endoscopy , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Gastrointestinal Hemorrhage/pathology , Humans , Inflammatory Bowel Diseases/pathology , Male , Middle Aged , Retrospective Studies , Spain , Tertiary Care Centers , Young Adult
8.
Rev. esp. enferm. dig ; 108(12): 817-818, dic. 2016. ilus
Article in Spanish | IBECS | ID: ibc-159632

ABSTRACT

Presentamos el caso de una mujer de 44 años de edad con antecedentes de abortos de repetición y síndrome de Budd-Chiari secundario a una mielofibrosis primaria en tratamiento anticoagulante. Consulta por melenas y astenia, presentando anemización progresiva. En una gastroscopia inicial se aprecia una compresión extrínseca a nivel supraampular de segunda porción duodenal, con una úlcera asociada en cara posterior de bulbo y primera rodilla. Posteriormente se diagnostica mediante una tomografía computarizada de un hematoma retroperitoneal espontáneo secundario a anticoagulación. Se trata con drenaje percutáneo y retirada de anticoagulación con buena respuesta inicial. No obstante, presenta complicaciones trombóticas (trombosis subclavia y yugular) y se reintroducen los anticoagulantes con dosis en el límite bajo del rango terapéutico (AU)


We present the case of a 44-year-old woman with past history of repeated miscarriage and Budd-Chiari syndrome secondary to primary myelofibrosis. Because of this she was under treatment with oral anticoagulant agents. The patient was admitted in hospital as she presented with gastrointestinal bleeding (melena), asthenia and progressive anemia. In an initial upper endoscopy an extrinsic duodenal compression associated with an ulcer on the posterior face of the first portion of duodenum and upper duodenal knee was observed. In the following days a huge spontaneous retroperitoneal hematoma due to anticoagulation was diagnosed by computed tomography. This was treated with a percutaneous drainage and withdrawal of the antithrombotic drugs. The evolution of the patient was initially satisfactory but she suffered subclavian and jugular vein thrombosis, and reintroduction of anticoagulant agents at the lowest therapeutic doses was required (AU)


Subject(s)
Humans , Female , Adult , Gastrointestinal Hemorrhage/complications , Gastrointestinal Hemorrhage/pathology , Gastrointestinal Hemorrhage , Retroperitoneal Neoplasms/complications , Retroperitoneal Neoplasms , Gastroscopy/methods , Bone Marrow/pathology , Bone Marrow/surgery , Acenocoumarol/therapeutic use , Primary Myelofibrosis/complications , Primary Myelofibrosis/pathology , Primary Myelofibrosis
9.
Rev Esp Enferm Dig ; 108(12): 817-818, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26864533

ABSTRACT

We present the case of a 44-year-old woman with past history of repeated miscarriage and Budd-Chiari syndrome secondary to primary myelofibrosis. Because of this she was under treatment with oral anticoagulant agents. The patient was admitted in hospital as she presented with gastrointestinal bleeding (melena), asthenia and progressive anemia. In an initial upper endoscopy an extrinsic duodenal compression associated with an ulcer on the posterior face of the first portion of duodenum and upper duodenal knee was observed. In the following days a huge spontaneous retroperitoneal hematoma due to anticoagulation was diagnosed by computed tomography. This was treated with a percutaneous drainage and withdrawal of the antithrombotic drugs. The evolution of the patient was initially satisfactory but she suffered subclavian and jugular vein thrombosis, and reintroduction of anticoagulant agents at the lowest therapeutic doses was required.


Subject(s)
Anticoagulants/adverse effects , Gastrointestinal Hemorrhage/chemically induced , Gastrointestinal Hemorrhage/diagnostic imaging , Hematoma/chemically induced , Hematoma/diagnostic imaging , Retroperitoneal Space/diagnostic imaging , Adult , Anticoagulants/therapeutic use , Budd-Chiari Syndrome/drug therapy , Duodenum/pathology , Female , Humans , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...